Clinical Pharmacology Details


OSELTAMIVIR


View Drug Forms

Indications & Dose:

BY MOUTH
Treatment of uncomplicated influenza infection in adults who have been symptomatic for no more than 2 days; reduces median time to improvement of symptoms by 1.3 days


Adult and child >16yr


PO 75 mg bid for 10 days, for post exposure prophylaxis for up to six weekes during an epedemic; dose adjustment for renal insufficiency: if CrCI < 30 mm/min, give 75 mg q day for 5 days


Child 1-3 years , body weight under 15 kg 30 mg once daily , body weight under 15 kg -30kg 45mg once daily ,body weight under 23-40 kg 60 mg once daily , over 40 kg adult dose. 

Contraindications:

Side Effects:

CNS: Insomnia, vertigo
GI: Nausea (10%)

Cautions:

Precautions:

Interaction:

Warnings:

Adverse Effects:

Lactations:

Special Precautions:

Counselling:

Side Effects Or Adverse Reactions:

Patient And Carer Advice: